Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

292
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
292
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

199
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
199
Censoring Survival Data01:09

Censoring Survival Data

243
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
243
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

404
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
404
Randomized Experiments01:13

Randomized Experiments

7.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.3K
Survival Curves01:18

Survival Curves

328
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
328

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two-Stage Double-Arm Trial Optimal Design of Restricted Mean Survival Time With Sculpted Critical Region.

Statistics in medicine·2026
Same author

ESPLSM: An Efficient and Interpretable Mediation Analysis Framework Using Sparse Envelopes.

Statistics in medicine·2026
Same author

Boreal Forest Sensitivity to Temperature Is Jointly Regulated by Ecosystem Productivity and Seasonality: A Synthesis Based on Carbon Fluxes From FLUXNET Sites.

Plant, cell & environment·2026
Same author

Dual-functional magnetic MXene@Fe<sub>3</sub>O<sub>4</sub>@ag NPs with synergistic enhancement for SERS detection and photo-Fenton degradation of organic pollutants.

Journal of colloid and interface science·2025
Same author

Dynamic hot spots engineering via tyramine-triggered AgAu Nanoassembly: A colloidal Interface strategy for ultrasensitive SERS detection of mycotoxins.

Journal of colloid and interface science·2025
Same author

MARGO: Machine Learning-Assisted Adaptive Randomization for Group Sequential Trials Based on Overlap Weights.

Statistics in medicine·2025
Same journal

Regression analysis of misclassified current status data with potentially unknown test accuracy.

Statistical methods in medical research·2026
Same journal

Bayesian multivariate linear mixed-effects models with varied association structures.

Statistical methods in medical research·2026
Same journal

Inference about the ratio of age-standardized rates between two overlapping populations.

Statistical methods in medical research·2026
Same journal

A robust neural network with random effects for subject-specific prediction of clustered count data.

Statistical methods in medical research·2026
Same journal

A comparison of methods for designing hybrid type 2 cluster-randomized trials with continuous effectiveness and implementation endpoints.

Statistical methods in medical research·2026
Same journal

Joint analysis of longitudinal and recurrent event data: A functional regression approach with autoregressive frailty.

Statistical methods in medical research·2026
See all related articles

Related Experiment Video

Updated: Sep 15, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Group sequential designs for survival outcomes with adaptive randomization.

Yaxian Chen1, Yeonhee Park2

  • 1Department of Statistics and Actuarial Science, The University of Hong Kong, China.

Statistical Methods in Medical Research
|July 17, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a flexible new Covariate-Adjusted Response-Adaptive Randomization (CARA) method for survival outcomes, improving clinical trial efficiency and patient-centered care. The CARAS design enhances statistical rigor while mitigating risks associated with model misspecification.

Keywords:
Cox modellog-rank testoptimal allocation ratiooverlap weightsurvival outcome

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Related Experiment Videos

Last Updated: Sep 15, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Survival Analysis

Background:

  • Modern clinical trials require innovative designs balancing statistical rigor and ethical considerations, adapting to evolving FDA recommendations.
  • Covariate-Adjusted Response-Adaptive Randomization (CARA) designs optimize treatment allocation based on patient profiles but often rely on restrictive parametric models for survival outcomes.
  • Existing CARA methods for survival data face limitations due to model misspecification risks, hindering broad clinical application.

Purpose of the Study:

  • To propose a novel CARA method for survival outcomes (CARAS) that enhances model flexibility and reduces the risk of misspecification.
  • To introduce a group sequential overlap-weighted log-rank test for maintaining type I error rates in CARAS trials.
  • To evaluate the clinical benefits, statistical efficiency, and robustness of the CARAS design.

Main Methods:

  • Developed a new CARA method for survival outcomes based on the flexible Cox model.
  • Introduced a group sequential overlap-weighted log-rank test for type I error control.
  • Conducted comprehensive simulation studies and analyzed a real-world clinical trial example.

Main Results:

  • The proposed CARAS method demonstrated improved model flexibility and robustness to misspecification compared to traditional designs.
  • The group sequential test effectively preserved the type I error rate in simulated trials.
  • Simulations and the real-world example confirmed the CARAS design's statistical efficiency and clinical benefits.

Conclusions:

  • The novel CARAS method offers a more flexible and robust approach for adaptive clinical trials with survival outcomes.
  • CARAS enhances statistical efficiency and maintains ethical considerations by personalizing treatment allocation.
  • This innovative design addresses limitations of existing CARA methods, paving the way for wider adoption in clinical practice.